Quad 4™ Intramedullary Nail System

...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...

...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...

...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...

...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...

(Date:12/2/2008)...SCO, Calif., Dec. 1 diaDexus, Inc....l for the automated format of the,PLAC Test for L... capable of,running on a wide range of clinical c...Food & Drug Administration (FDA) in December 2...f the CE Marked PLAC Test to Europe. , The ...

(Date:12/2/2008)...e health differences between groups of immigrants ... are also great. The differences are seen for risk...ew report from the Norwegian Institute of Public H...ompared with each other and the ethnic Norwegian p... target health care better. , The five immigran...

(Date:12/2/2008)... 2 Smile Reminder, the nation,s le..., unveiled the latest in industry,technology toda...igital tool,for capturing and distributing video ...atient testimonials onto popular platforms such as...w tool provides doctors with an effective,busines...

(Date:12/2/2008)...for Tuesday, December 2, 2008 at 3 pm CST)--Radiol...l University of South Carolina in Charleston, S.C....ncer from exposure to radiation during computed to...tated and that new estimates are several times low...C researchers presented their findings at the ann...

...cancer is the fourth leading cause of cancer death...o are usually affected // It is one of the most d...n until it has spread to other parts. Only about f...cancer patients survive the first five years after...

... comes in the way of the physical and mental growt...Tuesday stressing// on the need to "protect, prese...ting the first Global Youth Meet on Health in the ...lso a fundamental human right. While every citizen...

...e remedy of choice for treatment of influenza is c...ports of psychiatric// side effects, regulators s... change after series of cases of self-injury and m...y people who had been taking this drug Unfortunat...

...article published in the Lancet has brought to lig...blems for the Indian //community. With only 2.2per...he category of obese this clearly shows that the I.... It is estimated that 12 percent of the adult po...

(Date:12/2/2008)...A, Kan., Dec. 2 IBT Laboratories, ...earch laboratory specializing in immunology and al...tests to evaluate the response of patients whose ... immunodeficiency disorder, chemotherapy drugs, or...to prevent rejection of a transplant. The company ...

(Date:12/1/2008)... , , CHICAGO, Dec. 2 /PRNewswire-USNewswir...mography (PEM), a new technique for imaging the br...a woman,s hormonal status, two factors that limit ...at detecting cancer. Results will be presented tod...ty of North America (RSNA). , , "The abili...

(Date:12/1/2008)...Girl with Hypophosphatasia Treated With ENB-0040 a...innipeg , , MONTREAL, Dec. 1 /PRNewswire/ -...any focused on developing novel therapeutics for s...rst infant patient in its clinical program for hyp...nzyme Replacement Therapy (ERT) with ENB-0040 for ...

(Date:12/1/2008)...nference Call Scheduled for Tuesday, December 9 at...ML -- , , SOUTH SAN FRANCISCO, Calif., Dec...icals, Inc. (Nasdaq: SNSS ), a biopharmaceutical...ization of new oncology therapeutics, today announ...e myeloid leukemia (AML) will be presented during ...

...GE, Mass.--(BUSINESS WIRE)--Apr 17, 2007 - Alnylam...NAi therapeutics,company, announced today at the A...7 Annual Meeting that it will advance a,systemical...treatment of liver cancer and potentially other so... is an RNAi therapeutic that is,designed to target...

...IEJO, Calif.--(BUSINESS WIRE)--Apr 18, 2007 - Avan...ositive top-line,results from the company,s Phase ...drug Zenvia(TM) (dextromethorphan,hydrobromide/qui...gma-1 agonist, in diabetic neuropathic pain., The ...ly diary,entries for the Pain Rating Scale as defi...